NCT07517991

Brief Summary

Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth and is associated with both local tissue destruction and systemic inflammatory responses. Non-surgical periodontal therapy, particularly scaling and root planing (SRP), is the primary treatment approach; however, it may not completely eliminate pathogenic microorganisms in all cases. Adjunctive antimicrobial agents may improve treatment outcomes by enhancing bacterial reduction and modulating inflammation. Chlorhexidine (CHX) is widely used for its antimicrobial properties, while zinc has anti-inflammatory and immunomodulatory effects. The combined use of CHX and zinc may provide synergistic benefits in periodontal therapy. The aim of this randomized controlled clinical trial is to evaluate the clinical and biochemical effects of CHX and zinc as adjuncts to SRP in individuals with stage I and II periodontitis. A total of 44 systemically healthy participants will be randomly assigned to two groups. The test group will receive SRP with CHX and zinc, while the control group will receive SRP with distilled water. Clinical periodontal parameters (Plaque Index, Bleeding on Probing, Probing Pocket Depth, and Clinical Attachment Level) and biochemical markers (C-reactive protein, high-sensitivity CRP, Oncostatin M, and Antistreptolysin O) will be evaluated at baseline, 1 month, and 3 months. The results of this study are expected to provide evidence regarding the potential benefits of CHX and zinc in improving periodontal treatment outcomes and reducing systemic inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2026

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 2, 2026

Last Update Submit

April 18, 2026

Conditions

Keywords

ChlorhexidineZincScaling and Root PlaningNon-Surgical Periodontal TherapyInflammatory BiomarkersCRPOncostatin MRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Probing Pocket Depth (PPD)

    Measurement of periodontal pocket depth in millimeters to evaluate clinical periodontal improvement.

    Baseline, 1 month, and 3 months

  • Clinical Attachment Level (CAL)

    Assessment of clinical attachment level in millimeters as an indicator of periodontal tissue healing.

    Baseline, 1 month, and 3 months

Secondary Outcomes (6)

  • Plaque Index (PI)

    Baseline, 1 month, and 3 months

  • Bleeding on Probing (BOP)

    Baseline, 1 month, and 3 months

  • C-Reactive Protein (CRP)

    Baseline, 1 month, and 3 months

  • High-Sensitivity C-Reactive Protein (hs-CRP)

    Baseline, 1 month, and 3 months

  • Oncostatin M (OSM)

    Baseline, 1 month, and 3 months

  • +1 more secondary outcomes

Study Arms (2)

Chlorhexidine-Zinc Adjunctive SRP

EXPERIMENTAL

Participants receive scaling and root planing with adjunctive chlorhexidine and zinc.

Procedure: Chlorhexidine and zinc application

SRP with Distilled Water

ACTIVE COMPARATOR

Participants receive scaling and root planing (SRP) using an ultrasonic device with distilled water.

Procedure: Scaling and root planing with distilled water

Interventions

Scaling and root planing is performed using an ultrasonic device with a solution containing chlorhexidine and zinc.

Chlorhexidine-Zinc Adjunctive SRP

Scaling and root planing is performed using an ultrasonic device with distilled water.

SRP with Distilled Water

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged between 18 and 65 years
  • Systemically healthy individuals
  • Diagnosed with Stage I or Stage II periodontitis according to the 2017 classification
  • Having probing pocket depth ≤5 mm and clinical attachment loss ≤4 mm
  • Having a sufficient number of teeth for periodontal evaluation
  • Willing to participate and able to provide informed consent

You may not qualify if:

  • Presence of systemic diseases affecting periodontal health
  • Pregnancy or breastfeeding
  • Smoking
  • Use of antibiotics or anti-inflammatory drugs within the last 6 months
  • History of periodontal treatment within the last 6 months
  • Fewer than 15 teeth present
  • History of radiotherapy or chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University Faculty of Dentistry

Erzurum, Erzurum, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Periodontitis

Interventions

ChlorhexidineTooth ExfoliationRoot Planing

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Officials

  • Alparslan Dilsiz, Professor

    Ataturk University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The clinical outcome assessor is blinded to group allocation. The operator performing the treatment is aware of the intervention, while participants are not explicitly informed about group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to two parallel groups: a test group receiving scaling and root planing with chlorhexidine and zinc, and a control group receiving scaling and root planing with distilled water.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 8, 2026

Study Start

June 16, 2025

Primary Completion

March 26, 2026

Study Completion

April 1, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations. The study involves a limited number of participants from a single center, and no formal data-sharing plan has been established.

Locations